Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Ho

Showing results (91-100 of 321) with videos related to

Pageof 33
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myelomaB Kasper, T Moehler, K Neben, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Leukemia Research|January 1, 1983
Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3)A D Ho, D D Ma, G Price, et al.
British Journal of Haematology|March 29, 2002
A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13-cis retinoic acidM Görner, R Seggewiss, T Schlenker, et al.
British Medical Journal|January 14, 1978
Normotensive familial phaeochromocytoma with predominant noradrenaline secretionA D Ho, G Feurle, K H Gless, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex methodM Volm, T Efferth, M Bak, et al.
Deutsche Medizinische Wochenschrift (1946)|May 30, 1986
[Results with the use of the M-2 protocol in plasmacytoma]A D Ho, S Wittkamp, H Theml, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone in relapsed and refractory acute leukemiaH G Prentice, G Robbins, D D Ma, et al.
Cancer Gene Therapy|September 7, 2000
Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organsC Fiehn, N Wettschureck, A Krauthoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNAF Bellos, H Goldschmidt, M Dörner, et al.
Pageof 33

Showing results (91-100 of 321) with videos related to

Sort By:
Pageof 33
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myelomaB Kasper, T Moehler, K Neben, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Leukemia Research|January 1, 1983
Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3)A D Ho, D D Ma, G Price, et al.
British Journal of Haematology|March 29, 2002
A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13-cis retinoic acidM Görner, R Seggewiss, T Schlenker, et al.
British Medical Journal|January 14, 1978
Normotensive familial phaeochromocytoma with predominant noradrenaline secretionA D Ho, G Feurle, K H Gless, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Detection of the multidrug resistant phenotype in human tumours by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex methodM Volm, T Efferth, M Bak, et al.
Deutsche Medizinische Wochenschrift (1946)|May 30, 1986
[Results with the use of the M-2 protocol in plasmacytoma]A D Ho, S Wittkamp, H Theml, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone in relapsed and refractory acute leukemiaH G Prentice, G Robbins, D D Ma, et al.
Cancer Gene Therapy|September 7, 2000
Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organsC Fiehn, N Wettschureck, A Krauthoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNAF Bellos, H Goldschmidt, M Dörner, et al.
Pageof 33